PIK3CAH1047R induces multipotency and multi-lineage mammary tumours

Nature

Volumn 525, Issue 7567, 2015, Pages 114-118

  Koren, Shany ^a   Reavie, Linsey ^a   Couto, Joana Pinto ^a   De Silva, Duvini ^a   Stadler, Michael B ^a,b   Roloff, Tim ^a   Britschgi, Adrian ^a   Eichlisberger, Tobias ^a   Kohler, Hubertus ^a   Aina, Olulanu ^c   Cardiff, Robert D ^c   Bentires Alj, Mohamed ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; TAMOXIFEN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN;

CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; GENOMICS; LESION; MUTATION; RODENT; TUMOR;

ADULT; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL; BREAST CANCER; BREAST EPITHELIUM CELL; CELL DEDIFFERENTIATION; CELL EXPANSION; CELL LABELING; CELL LINEAGE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INTERNAL RIBOSOME ENTRY SITE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; TUMOR INVASION; UDDER;

ANIMALS; BREAST NEOPLASMS; CELL DEDIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MULTIPOTENT STEM CELLS; MUTATION; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84940937183     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14669     Document Type: Article

References (32)

1. Van Keymeulen, A. et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 479, 189-193 (2011).
2. van Amerongen, R., Bowman, A. N. & Nusse, R. Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 11, 387-400 (2012).
3. + cells to basal and luminal epithelial lineages in the postnatal mammary gland. J. Pathol. 228, 300-309 (2012).
4. Tao, L., van Bragt, M. P., Laudadio, E. & Li, Z. Lineage tracing ofmammary epithelial cells using cell-type-specific Cre-expressing adenoviruses. Stem Cell Rep. 2, 770-779 (2014).
5. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
6. Hennighausen, L. & Robinson, G. W. Signaling pathways in mammary gland development. Dev. Cell 1, 467-475 (2001).
7. Spike, B. T. et al. A mammary stemcell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 10, 183-197 (2012).
8. Shackleton, M. et al. Generation of a functionalmammary gland froma single stem cell. Nature 439, 84-88 (2006).
9. Stingl, J. et al. Purification andunique properties ofmammary epithelial stemcells. Nature 439, 993-997 (2006).
10. Sleeman, K. E. et al. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J. Cell Biol. 176, 19-26 (2007).
11. Prater, M. D. et al. Mammary stem cells havemyoepithelial cell properties. Nature Cell Biol. 16, 942-950 (2014).
12. Rios, A. C., Fu, N. Y., Lindeman, G. J. & Visvader, J. E. In situ identification of bipotent stem cells in the mammary gland. Nature 506, 322-327 (2014).
13. Wang, D. et al. Identification of multipotent mammary stem cells by protein C receptor expression. Nature 517, 81-84 (2015).
14. Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004).
15. Koren, S. & Bentires-Alj, M. Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors. FEBS J. 280, 2758-2765 (2013).
16. Meyer, D. S. et al. Luminal expression of PIK3CA mutant H1047R in themammary gland induces heterogeneous tumors. Cancer Res. 71, 4344-4351 (2011).
17. Liu, P. et al. Oncogenic PIK3CA-drivenmammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms. Nature Med. 17, 1116-1120 (2011).
18. Meyer, D. S. et al. Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R. Oncogenesis 2, e74 (2013).
19. Plaks, V. et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Rep. 3, 70-78 (2013).
20. Sleeman, K. E., Kendrick, H., Ashworth, A., Isacke, C. M. & Smalley, M. J. CD24 staining ofmousemammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res. 8, R7 (2006).
21. Meier-Abt, F. et al. Parity induces differentiation and reducesWnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res. 15, R36 (2013).
22. Lim, E. et al. Transcriptome analyses of mouse and human mammary cell subpopulations revealmultiple conserved genes and pathways. Breast Cancer Res. 12, R21 (2010).
23. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Med. 15, 907-913 (2009).
24. Molyneux, G. et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7, 403-417 (2010).
25. Kinzel, B. et al. Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. Dev. Biol. 390, 181-190 (2014).
26. Sommer, C., Strähle, C., Köthe, U. & Hamprecht, F.A. Ilastik: Interactive Learning and Segmentation Toolkit. Proc. Eighth IEEE Int. Symp. Biomed. Imag. 230-233 (2011).
27. Cicalese, A. et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095 (2009).
28. Deome, K. B., Faulkin, L. J. Jr, Bern, H. A. & Blair, P. B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515-520 (1959).
29. Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70-78 (2009).
30. Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363-2367 (2010).
31. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 42, D7-D17 (2014).
32. Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 11, 367 (2010).